Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical rh-bFGF after FESS for chronic rhinosinusitis
ChiCTR2000032203Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of trafermin in chronic rhinosinusitis (CRS) (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Nasal symptom visual analog scale score, Sinusitis Quality of Life Scale (SNOT-20) and 5 more. Started Apr 2019; status: recruiting.
02
Drugs
trafermin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ChiCTR2000032203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032203.